In regards to epilepsy, CBD has been shown to provide substantial relief from symptoms of epilepsy in patients with the disorder. In 2015 there was a law passed allowing clinical trials in Alabama to research cannabidiol, widely known as Carly’s Law. The University of Alabama conducted a study in which they discovered that seizure frequency was drastically reduced when CBD was supplemented. They had 132 patients for this survey, 60 adults and 72 children. Patients had intractable epilepsy, and prior forms of treatment proved to be ineffective.
They had patients tested at 3 months, 6 months, and lastly at 11 months. Baseline seizure rates were recorded. The mean between all 132 patients at the beginning of these clinical trials was 144 seizures within 2 weeks. The addition of CBD oil had reduced the mean to a rate of 52 seizures within a 2-week time frame. This remained consistent for the duration of the trial. These results speak to the benefits of the CBD effects.
